Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
EBioMedicine (2022) - Comments
pubmed: 35617826  doi: 10.1016/j.ebiom.2022.104073  issn: 2352-3964 

Zoltán Bánki, Jose Mateus, Annika Rössler, Helena Schäfer, David Bante, Lydia Riepler, Alba Grifoni, Alessandro Sette, Viviana Simon, Barbara Falkensammer, Hanno Ulmer, Bianca Neurauter, Wegene Borena, Florian Krammer, Dorothee Von Laer, Daniela Weiskopf, Janine Kimpel, Petra Flatscher, Lukas Forer, Elisabeth Graf